| Literature DB >> 36085058 |
Haiping Lin1, Minhao Yu1, Guangyao Ye1, Shaolan Qin1, Hongsheng Fang1, Ran Jing1, Tingyue Gong1, Yang Luo2, Ming Zhong3.
Abstract
BACKGROUND: Anastomotic leakage (AL) is one of most severe postoperative complications following low anterior resection (LAR) for rectal cancer, and has an adverse impact on postoperative recovery. The occurence of AL is associated with several factors, while few studies explored the role of intracorporeal barbed suture reinforcement in it.Entities:
Keywords: Anastomotic leakage; Barbed suture; Intracorporeal reinforcement; Laparoscopic low anterior resection; Rectal cancer
Mesh:
Year: 2022 PMID: 36085058 PMCID: PMC9461121 DOI: 10.1186/s12893-022-01782-x
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Fig. 1Flowchart showing selection processes
Baseline characteristics, intraoperative and postoperative outcomes between the intracorporeal barbed suture reinforcement and control groups
| Intracorporeal barbed suture reinforcement group | Control group | |
|---|---|---|
| Age (year) | 65.00 (7.53) | 59.50 (10.57) |
| Sex | ||
| Male | 79 (55.63%) | 78 (52.00%) |
| Female | 63 (44.37%) | 72 (48.00%) |
| BMI (kg/m2) | 22.28 (2.85) | 21.41 (2.89) |
| ASA | ||
| Grade 1 | 70 (49.30%) | 93 (62.00%) |
| Grade 2 | 70 (49.30%) | 55 (36.67%) |
| Grade 3 | 2 (1.41%) | 2 (1.33%) |
| Smoking | ||
| Yes | 39 (27.46%) | 37 (24.67%) |
| No | 103 (72.54%) | 113 (75.33%) |
| Diabetes | ||
| Yes | 21 (14.79%) | 14 (9.33%) |
| No | 121 (85.21%) | 136 (90.67%) |
| Anemia | ||
| Yes | 17 (11.97%) | 17 (11.33%) |
| No | 125 (88.03%) | 133 (88.67%) |
| Preoperative albumin level | ||
| Normal | 138 (97.18%) | 146 (97.33%) |
| Low | 4 (2.82%) | 4 (2.67%) |
| Preoperative adjuvant chemoradiotherapy | ||
| Yes | 18 (12.68%) | 15 (10.00%) |
| No | 124 (87.32%) | 135 (90.00%) |
| Previous abdominal surgery history | ||
| Yes | 7 (4.93%) | 6 (4.00%) |
| No | 135 (95.07%) | 144 (96.00%) |
| Tumor size (cm) | 3.75 (1.48) | 4.00 (1.57) |
| Stage | ||
| Stage I | 13 (9.15%) | 9 (6.00%) |
| Stage II | 48 (33.80%) | 57 (38.00%) |
| Stage III | 81 (57.04%) | 84 (56.00%) |
| Tumor distance (cm) | 7.00 (1.18) | 7.00 (1.27) |
| Stapler firings | ||
| < 3 | 133 (93.66%) | 142 (94.67%) |
| ≥ 3 | 9 (6.34%) | 8 (5.33%) |
| Reserve of LCA | ||
| Yes | 86 (60.56%) | 89 (59.33%) |
| No | 56 (39.44%) | 61 (40.67%) |
| Anastomosis level (cm) | 3.00 (1.10) | 3.00 (1,19) |
| Number of retrieved LNs | 17.00 (4.62) | 16.50 (3.88) |
| Surgical time (min) | 147.50 (35.05) | 130.00 (32.07) |
| Estimated blood loss (ml) | 100.00 (73.96) | 100.00 (75.01) |
| Postoperative ventilation time (h) | 60.00 (20.03) | 72.00 (19.74) |
| AL | ||
| Yes | 4 (2.82%) | 15 (10.00%) |
| No | 138 (97.18%) | 135 (90.00%) |
| Hospital stay (day) | 7.50 (3.18) | 8.00 (4.12) |
BMI body mass index, ASA American Society of Anesthesiologist, CEA carcinoma embryonic antigen, LCA left colic artery, LN lymph node, AL anastomotic leakage
Fig. 2Anastomosis status examined by colonoscopy 6 months after surgery in (A) the intracorporeal barbed suture reinforcement group and (B) the control group
Baseline characteristics, intraoperative and postoperative outcomes between the intracorporeal barbed suture reinforcement and control groups in matched patients
| Intracorporeal barbed suture reinforcement group | Control group | Standardized difference | |
|---|---|---|---|
| Age (year) | 65.00 (6.71) | 60.00 (10.70) | 0.642 |
| Sex | 0.033 | ||
| Male | 67 (54.47%) | 65 (52.85%) | |
| Female | 56 (45.53%) | 58 (47.15%) | |
| BMI (kg/m2) | 22.32 (2.74) | 21.51 (2.77) | 0.059 |
| ASA | 0.232 | ||
| Grade 1 | 61 (49.59%) | 75 (60.98%) | |
| Grade 2 | 61 (49.59%) | 47 (38.21%) | |
| Grade 3 | 1 (0.81%) | 1 (0.81%) | |
| Smoking | < 0.001 | ||
| Yes | 32 (26.02%) | 32 (26.02%) | |
| No | 91 (73.98%) | 91 (73.98%) | |
| Diabetes | 0.222 | ||
| Yes | 20 (16.26%) | 11 (8.94%) | |
| No | 103 (83.74%) | 112 (91.06%) | |
| Anemia | 0.053 | ||
| Yes | 14 (11.38%) | 12 (9.76%) | |
| No | 109 (88.62%) | 111 (90.24%) | |
| Preoperative albumin level | < 0.001 | ||
| Normal | 120 (97.56%) | 120 (97.56%) | |
| Low | 3 (2.44%) | 3 (2.44%) | |
| Preoperative adjuvant chemoradiotherapy | 0.028 | ||
| Yes | 11 (8.94%) | 12 (9.76%) | |
| No | 112 (91.06%) | 111 (90.24%) | |
| Previous abdominal surgery history | 0.039 | ||
| Yes | 5 (4.07%) | 6 (4.88%) | |
| No | 118 (95.93%) | 117 (95.12%) | |
| Tumor size (cm) | 4.00 (1.46) | 4.00 (1.63) | 0.164 |
| Stage | 0.098 | ||
| Stage I | 10 (8.13%) | 7 (5.69%) | |
| Stage II | 41 (33.33%) | 43 (34.96%) | |
| Stage III | 72 (58.54%) | 73 (59.35%) | |
| Tumor distance (cm) | 7.00 (1.14) | 7.00 (1.23) | 0.033 |
| Stapler firings | < 0.001 | ||
| < 3 | 115 (93.50%) | 115 (93.50%) | |
| ≥ 3 | 8 (6.50%) | 8 (6.50%) | |
| Reserve of LCA | 0.117 | ||
| Yes | 79 (64.23%) | 72 (58.54%) | |
| No | 44 (35.77%) | 51 (41.46%) | |
| Anastomosis level (cm) | 3.00 (1.10) | 3.00 (1.18) | 0.043 |
| Number of retrieved LNs | 18.00 (4.83) | 17.00 (3.79) | 0.224 |
| Surgical time (min) | 150.00 (33.12) | 130.00 (30.46) | 0.576 |
| Estimated blood loss (ml) | 100.00 (69.15) | 100.00 (74.56) | 0.027 |
| Postoperative ventilation time (h) | 72.00 (19.78) | 72.00 (19.76) | 0.137 |
| AL | 0.334 | ||
| Yes | 3 (2.44%) | 13 (10.57%) | |
| No | 120 (97.56%) | 110 (89.43%) | |
| Hospital stay (day) | 7.00 (2.32) | 8.00 (4.14) | 0.313 |
BMI body mass index, ASA American Society of Anesthesiologist, CEA carcinoma embryonic antigen, LCA left colic artery, LN lymph node, AL anastomotic leakage